SLC2A1 and epilepsy: Whether a variability could actually occur should be worthy of investigation since reduced KBs levels could lead to increased seizure presentation in patients with drug resistant epilepsy and even movement disorder manifestation or increased fatigue and reduced attention in patients with GLUT1-DS.